Patients with either hepatic metastasis or peritoneal dissemination did not survive 5 years.

Conclusion: The incidence of CRC recurrence after LR for hepatic metastasis remains very high.

Nodal and hepatic metastasis presented with both cellular types, with dominance of the squamous component.

Case presentation: We report a 69-year-old patient with non-resectable CC showing hepatic metastasis and peritoneal carcinomatosis.

The diagnosis of hepatic abscess and hepatic metastasis was made using pathological confirmation or clinical diagnosis.

Currently, the genes and molecular mechanisms that are functionally critical in modulating colorectal cancer hepatic metastasis remain unclear.

One year after surgery, a PET-CT and a scintigraphy revealed the presence of a cervical recurrence and hepatic metastasis.

The incidence of hepatic metastasis was assessed by magnetic resonance imaging and histology over the 13 months of follow-up.

The roles of chemotherapy, surgery, and radiation therapy in the management of symptomatic hepatic metastasis from neuroblastoma are discussed.

The echocardiogram showed a mass in the right atrial cavity and the CT scan showed extensive local invasion and hepatic metastasis.

Nor was the presence of hepatic metastasis associated with lower outcome (p = 0.77).

Methods: From 1986 to 2000, 181 patients underwent liver resection for hepatic metastasis from colorectal cancer.

Material and methods: Twenty patients with known hepatic metastasis underwent MR imaging using mangafodipir trisodium and ferucarbotran in at least 1-day intervals.

We present our experience in the use of hepatic artery chemoembolization in the treatment of patients with hepatic metastasis from neuroendocrine tumors.

In this study, we aimed to analyze the outcomes of patients with CRC hepatic metastasis in terms of the era of treatment.

Objectives: We aimed to identify features that differentiate hepatic microabscess from hepatic metastasis on gadoxetic acid-enhanced MRI in patients with periampullary cancer.